30 likes | 35 Views
CMOAPI has a full range of raw materials of lorcaserin , and has a total quality management system.Also passed GMP and DMF certification. Visit: https://www.cmoapi.com/our-products/lorcaserin/
E N D
What drugs and food should I avoid while taking Belviq? Whenafoodaffectsmedicationsinthebody,thisiscalled food-druginteraction.Foodcanpreventmedicinefromworkingthe wayitshouldandcancausemedicinalsideeffectstobecomebetter orworseand/orcausenewsideeffectstooccur. Avoiddrivingorhazardousactivityuntilyouknowhowthis medicinewillaffectyou.Yourreactionscouldbeimpaired. Avoidtakingcoughandcoldorallergymedicationswhiletaking lorcaserin. Whatotherdrugswillaffectlorcaserin? Tellyourdoctoraboutallyourcurrentmedicinesandanyyoustart orstopusing,especially: cabergoline; linezolid; lithium; St.John'swort; tramadol; tryptophan(alsocalledL-tryptophan); anytypeofantidepressant; coldorcoughmedicinethatcontainsdextromethorphan(acough suppressant);
erectile dysfunction medicine--avanafil, sildenafil, tadalafil, Cialis, Levitra, Viagra, and others; medicine to treat mental illness, anxiety, or a mood disorder; or a "triptan" migraine headache medicine--such as almotriptan, frovatriptan, rizatriptan, sumatriptan, zolmitriptan, Imitrex, Maxalt, Zomig, and others. This list is not complete. Other drugs may interact with lorcaserin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Reference 1. Patel DK, Stanford FC (March 2018). "Safety and tolerability of new-generation anti-obesity medications: a narrative review". Postgraduate Medicine (Narrative review). 130 (2): 173–182. doi:10.1080/00325481.2018.1435129. PMC 6261426. PMID 29388462. 2."Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)". U.S. Food and Drug Administration (FDA). 14 January 2020. Retrieved 14 January 2020. This article incorporates text from this source, which is in the public domain.
3. "FDA In Brief: FDA Requests Voluntary Withdrawal of Weight-Loss Medication After Clinical Trial Shows an Increased Occurrence of Cancer". FDA. 13 February 2020. https://www.cmoapi.com/ https://www.cmoapi.com/our-products/lorcaserin/ https://www.facebook.com/Cmoapi-114510347044359/ https://www.pinterest.com/cmoapibiotech/boards/ https://sites.google.com/view/cmoapi-lorcaserin-for-sell/